New Drugs and Devices for HF Therapy

Published: 31 July 2020

  • Views:

    Views Icon 57

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This session was part of the 1st e-SPACE Heart Failure Meeting held virtually on July 11-14th 2020 and focuses on novel drugs and devices changing the treatment paradigm in Heart Failure management.

Agenda

  • Omecamtiv Mecarbil for Chronic HF - John Teerlink (University of San Francisco, San Francisco, US)
  • Devices for Functional MR beyond Mitraclip - Ralph Stephan von Bardeleben (University of Mainz, Mainz, DE)
  • Devices for Baroreflex Stimulation - Andrew Coats (Monash University, Melbourne, AU)
  • More on New Drugs and Devices on the Horizon - Stefan Anker (Charite University, Berlin, DE)

More from this programme

Part 1

Omecamtiv Mecarbil for Chronic HF

1 session
Omecamtiv Mecarbil for Chronic HF Watch now

Part 2

Devices for Functional MR beyond Mitraclip

1 session
Devices for Functional MR beyond Mitraclip Watch now

Part 3

Devices for Baroreflex Stimulation

1 session
Devices for Baroreflex Stimulation Watch now

Part 4

More on New Drugs and Devices on the Horizon

1 session
More on new drugs and devices on the horizon Watch now

Faculty Biographies

Stefan Anker

Stefan Anker

Professor of Cardiology

Dr Stefan D Anker, Professor of Cardiology and Cachexia Research, Department of Cardiology, Charité Campus Virchow-Klinikum, Berlin, Germany, and served as the 2012–14 President of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). 

View full profile